Find your next paid study

Truway Health, Inc.NCT07321028

~$150 – $4,200

Actual pay is set by the research site.

PROspective Phase II Trial of Pre-operative Hypofractionated protoN Therapy for Extremity and Truncal Soft Tissue sarcOma

This study is being done to examine whether proton therapy for certain kinds of sarcomas (extremity and trunk soft tissue) is safe and effective. As part of th…

Soft Tissue Sarcoma

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT05917301

Actual pay is set by the research site.

Phase 1

SAINT: A Phase 1/2 Study of Safe Amounts of IPLIMUMAB, NIVOLUMAB and TRABECTEDIN for Previously Treated Advanced Soft Tissue Sarcoma (STS)

This is an open label, dose-seeking phase 1/2 study using escalating doses of TRABECTEDIN given intravenously with defined doses of IPILIMUMAB and NIVOLUMAB ba…

Advanced Soft Tissue SarcomaMetastatic Soft Tissue Sarcoma

Sarcoma Oncology Research Center, LLCNCT03138161

~$150 – $3,000

Actual pay is set by the research site.

Adolescent Alcohol UseMental Health IssueAlcohol Related Disorders+1 more

Virtual SBIRT for Pediatric Primary Care: Increasing Access to Screening, Brief Intervention and Referral to Treatment for Alcohol and Other Drug Use Via Telehealth

Adolescent alcohol and other drug (AOD) use is a significant public health problem which contributes to high levels of mortality, morbidity and healthcare cost…

Kaiser PermanenteNCT06486688

~$10 – $1,125

Actual pay is set by the research site.

Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders

A repository of biospecimens and detailed phenotypic information collected longitudinally from adults with congenital heart disease and related conditions, wit…

Adult Congenital Heart DiseasePulmonary HypertensionConnective Tissue Disease+1 more

Children's Hospital Medical Center, CincinnatiNCT07477197

~$10 – $675

Actual pay is set by the research site.

DepressionAnterior Cruciate Ligament InjuriesMental Health Issue

Randomized Control Trial of the Impact of a Virtual Psychological Intervention on the Outcomes of ACLR

The goal of this parallel arm prospective randomized control trial study is to compare outcomes in Anterior Cruciate Ligament Reconstruction (ACLR) Surgery pat…

Henry Ford Health SystemNCT05965310

Actual pay is set by the research site.

Distal Aortic DissectionDissection, Aortic AcuteAcute Type B Aortic Dissection (Uncomplicated)

A Randomized Controlled Comparative Study on Effectiveness of Endovascular Repair Versus Best Medical Therapy for Acute Uncomplicated Type B Aortic Dissection

The purpose of the study is to conduct a randomized controlled trial comparing best medical therapy (BMT) alone to BMT with thoracic endovascular aortic repair…

The University of Texas Health Science Center, HoustonNCT02622542

Actual pay is set by the research site.

LeukemiaAcute Myeloid Leukemia in RemissionMyelodysplasia+10 more

Matched Unrelated Donor and Partially Matched Related Donor Peripheral Stem Cell Transplantation With Alpha/Beta T-Cell and B-Cell Depletion for Patients With Hematologic Malignancies With Targeted ATG Dosing Pilot Study, IDE 13641

This is a single arm pilot study for patients with hematologic malignancies receiving unrelated or haploidentical related mobilized peripheral stem cells (PSCs…

Actual pay is set by the research site.

Phase 2

A Phase IIa Open Label Study Evaluating the Preliminary Efficacy of Intratumoural Tigilanol Tiglate in Advanced and/or Metastatic Soft Tissue Sarcoma of the Extremities and Body Wall.

A Phase IIa open label study evaluating the preliminary efficacy of intratumoural tigilanol tiglate in advanced and/or metastatic soft tissue sarcoma of the ex…

Soft Tissue Sarcoma

QBiotics Group LimitedNCT05755113

~$75 – $2,800

Actual pay is set by the research site.

Phase 1

A Phase I Open-Label, Dose Escalation Study of the Safety and Tolerability of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors

This is a Phase 1, multicenter, open-label dose escalation study to determine the safety and tolerability of intratumoral (IT) injection of tolododekin alfa (A…

Advanced Solid TumorCutaneous TumorSubcutaneous Tumor+6 more

Ankyra Therapeutics, IncNCT06171750

~$150 – $4,200

Actual pay is set by the research site.

Phase 3

An Open Label Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD)

This is an open label extension (OLE) study of an ongoing randomized controlled parent clinical studies 218224 (NCT05878717) and 221672 (NCT06572384) which aim…

Connective Tissue Diseases

GlaxoSmithKlineNCT06716606

~$50 – $2,250

Actual pay is set by the research site.

Phase 2

Phase 2 Trial of Epcoritamab in Patients With Newly Diagnosed Marginal Zone Lymphoma (MZL)

The purpose of this study is to assess if an investigational treatment of Epcoritamab will be beneficial for patients with Marginal Zone Lymphoma (MZL).

Marginal Zone LymphomaExtranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid TissueSplenic Marginal Zone Lymphoma+1 more